Introduction The manufacture of medicinal products in shared facilities is an established industrial practice,
Artificial intelligence is reshaping pharmaceuticals industry-not through generic algorithms alone, but by addressing real
In today’s rapidly evolving pharmaceutical ecosystem, the relationship between drug sponsors and their outsourced
INTERNATIONAL OLIGONUCLEOTIDES AND PEPTIDES CONFERENCE The IOPC is the leading event at the forefront
Synthetic Oligonucleotides and the oligonucleotide Space Synthetic oligonucleotides lie at the very core of
The manufacturing of antibody–oligonucleotide conjugates (AOCs) and oligo-peptide conjugates are transforming the precision, scalability,
Introduction Within the fields of chemistry and pharmaceuticals, claims are frequently formulated to safeguard
Context/Overview Breakthrough therapies often fail to reach patients. Not because biology doesn’t work, but
Introduction: From Digitalisation to Intelligence Over the past decade, many laboratories across the chemical
Introduction Biotech companies backed by venture capital or private equity face very different pressures
